PATENT CLAIM ANALYSIS

Application Number: 16150703
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-08
Patent Classification: ["514", "021400"]

Abstract:
This invention provides novel guanylate cyclase C (GC-C) agonists and their therapeutic use. The agonists may be used either alone or in combination with one or more additional agents.

Claim (Index 20):
The method of  claim 19 , wherein said peptide is Asn 1 -Asp 2 -Aad 3 -Cys 4 -Glu 5 -Leu 6 -Cys 7 -Val 8 -Asn 9 -Val 10 -Ala 11 -cys 12 -Thr 13 -Gly 14 -cys 15 -Leu 16  (SEQ ID NO: 1), Asn 1 -Asp 2 -Aad 3 -Cys 4 -Glu 5 -Leu 6 -Cys 7 -Val 8 -Asn 9 -Val 10 -Ala 11 -cys 12 -Thr 13 -Gly 14 -Cys 15 -Ser 16  (SEQ ID NO: 32), Asn 1 -Asp 2 -Aad 3 -Cys 4 -Glu 5 -Leu 6 -Cys 7 -Val 8 -Asn 9 -Val 10 -Ala 11 -Cys 12 -Thr 13 -Gly 14 -Cys 15 -Thr 16  (SEQ ID NO: 119), Asn 1 -Asp 2 -Aad 3 -Cys 4 -Glu 5 -Leu 6 -Cys 7 -Val 8 -Asn 9 -Val 10 -Ala 11 -cys 12 -Thr 13 -Gly 14 -Cys 15 -Tyr 16  (SEQ ID NO: 120), dAsn 1 -Asp 2 -Aad 3 -Cys 4 -Glu 5 -Leu 6 -Cys 7 -Val 8 -Asn 9 -Val 10 -Ala 11 -Cys 12 -Thr 13 -Gly 14 -cys 15 -dLeu 16  (SEQ ID NO: 17), or pyGlu 1 -Asp 2 -Aad 3 -Cys 4 -Glu 5 -Leu 6 -Cys 7 -Val 8 -Asn 9 -Val 10 -Ala 11 -Cys 12 -Thr 13 -Cys 14 -Cys 15 -Leu 16  (SEQ ID NO: 56).

Metadata:
- Claim Count in Document: 19.0
- Percentile: 97.0
- Lexical Diversity: 1.1
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14207753', '15622526', '14124282', '14124286', '13514158']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8439294381662208
- 35 USC 102 Novelty (BERT): 0.6469712541466662
- Combined Prediction Score: 0.8242336197642653
- Mean Citation Score: 551.340638
- Max Citation Score: 658.6026
- Similarity Product: 580.6922148810626

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test